Why the study?
Mitral annular disjunction is often poorly recognized and is a risk marker for ventricular arrhythmias and sudden cardiac death, but patient management and risk stratification are not systematized.
Mitral annular disjunction is an important risk marker for ventricular arrhythmias and sudden cardiac death in patients with mitral valve prolapse, highlighting the need for systematic risk stratification.
Answers are grounded in this paper and cite their sources.
May inform closer follow-up in mitral valve prolapse; leaves open prospective validation of stratification strategies.
Mitral annular disjunction (MAD) is an easily identifiable entity on transthoracic echocardiography, but is still poorly recognized or ignored. It is often associated with mitral valve prolapse and is itself a risk marker for ventricular arrhythmias and sudden cardiac death, but the management and risk stratification of these patients is not systematized. Two clinical cases of MAD associated with mitral valve prolapse and ventricular arrhythmias are presented. The first case is of a patient with a history of surgical intervention on the mitral valve due to Barlow's disease. He presented to the emergency department with sustained monomorphic ventricular tachycardia requiring emergent electrical cardioversion. MAD with transmural fibrosis at the level of the inferolateral wall was documented. The second report is of a young woman with palpitations and frequent premature ventricular contractions on Holter with documentation of valvular prolapse and MAD, and focuses on the risk stratification approach. The present article offers a review of the literature regarding the arrhythmic risk of MAD and mitral valve prolapse, as well as a review of risk stratification in these patients.
No takes yet. Share an insight, caveat, or question.
Faria et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: